Abstract-Focused ultrasound (FUS), in combination with microbubbles, has been found to open the blood-brain barrier (BBB) non-invasively. When this technique is used for drug delivery, repeated drug administration and BBB opening are likely required. Therefore, it is worth investigating the long-term effects of FUS-induced BBB opening. In this study, we focused on the assessment of potential behavior changes in mice that could be attributed to repeated BBB opening for up to 6 months. The striatum of animals was unilaterally sonicated either monthly or biweekly throughout the monitoring period. Behavioral assessments were conducted using open-field and rotarod performance tests. Upon completion of each sonication, mice underwent magnetic resonance imaging (MRI) to confirm and assess the volume of the BBB opening. No differences in locomotor activity between BBB-opened and control groups in both biweekly and monthly treated mice were evident up to 6 months. Similarly, there was no affinity for a particular turn angle in the sonicated mice compared with the control animals. However, the positive control group exhibited a significant decrease in locomotor activity, as well as rotation ipsilateral to the sonicated hemisphere. Our results based on the assessment using open-field and rotarod tests indicated that repeated opening of the BBB in the striatum using FUS in conjunction with microbubbles over a period of 6 mo and under the parameters used here did not cause motor impairment, behavioral changes or morphologic alterations. This reinforces the tolerability of repeated and long-term drug delivery using FUS-induced BBB
INTRODUCTION
The onset of Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons, with this loss confined to the nigrostriatal pathway. Although a comprehensive understanding of the etiology of PD remains under examination, much of the pathophysiology is understood (Katzenschlager and Lees 2002) . Treatment of PD has progressed immensely over the decades, namely with the introduction of levodopa in the 1960s (Katzenschlager and Lees 2002) . Levodopa alleviates the symptoms of PD through promotion of dopamine replacement for cells lost in the nigrostriatal pathway. However, effective administration of levodopa must be paired with a peripheral decarboxylase inhibitor (carbidopa); levodopa alone is unable to reach the brain parenchyma in adequate amounts without assistance. In addition, despite the understanding that levodopa metabolizes into dopamine on entering the brain, using dopamine as a method of therapy is impractical because of its associated impedance of the blood-brain barrier (BBB) and the inability of dopamine to penetrate the parenchyma efficiently. The BBB is a complex homeostatic system that effectively controls and limits influx and efflux of molecules between the brain and the vascular system (Sheikov et al. 2006) . Because of such factors as molecular size, hydrophobicity and atomic charge (Abbott et al. 2006) , the BBB severely limits the potential for systemic administration of therapeutic agents; the system effectively excludes 98% of small-molecule drugs and nearly all large-molecule drugs (Abbott 2013) .
Focused ultrasound (FUS), in combination with microbubbles, displays great potential in the ability to increase BBB permeability transiently and focally Ultrasound in Med. & Biol., Vol. 42, No. 9, pp. 2270 -2282 , 2016 Ó 2016 (Choi et al. 2010b; Hynynen et al. 2005; McDannold et al. 2006) . The role of microbubbles is fundamental to the mechanism of BBB opening with FUS. The acoustic emissions drive the cavitating microbubbles, which in turn exert shear stress on the vessel wall (Hosseinkhah et al. 2013) . The resulting shear stress is hypothesized to then disrupt the tight junction complex and allow active transport, through paracellular or transcellular endocytosis, of larger molecules, which may eventually diffuse into the brain parenchyma (Sheikov et al. 2004) .Various therapeutic agents have been successfully delivered through the BBB using FUS (Baseri et al. 2012; Fan et al. 2013; Jordão et al. 2013; Park et al. 2012; Wu et al. 2014 ). In the case of PD treatment, neurotrophic factors were reported to protect degenerating dopaminergic neurons, as well as promote regeneration of the nigrostriatal dopamine system (Rangasamy et al. 2010) . Several studies investigated the feasibility of FUS-facilitated delivery of neurotrophic factors to the brain using glia-derived neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF) and neurturin (NTN) (Baseri et al. 2012; Wang et al. 2012) . The success of this potential therapy would require repeated administration of neurotrophic factors and FUS-induced BBB opening. Therefore, the tolerability of longitudinal effects of FUS ultrasound on brain therapy is of great interest. Several previous studies explored the effects of repeated applications of FUS for drug delivery to the brain. Yang et al. (2011) reported that repeated sonications at 20-or 40-min intervals enhanced Evans blue extravasation in rat brains. Burgess et al. (2014) performed weekly sonications for 3 wk in a mouse model of Alzheimer disease, followed by a week of behavior testing. They reported plaque reduction and increased neuronal plasticity in mice treated with three-repeated BBB opening alone. Long-term studies in non-human primates were also reported showing no significant changes in MRI (Downs et al. 2014) or histologic examination . In this study, our aim was to investigate the long-term effects of repeated FUS-induced BBB opening in wild-type mice using behavioral assays and histological analysis.
METHODS

Animals
Wild-type mice were purchased from Harlan Laboratories (strain C57 BL/6) and were 8 wk of age at the beginning of the experiment. Table 1 summarizes the main experimental groups (n 5 5) used in this experiment, where the group name letter stands for either biweekly (B) or monthly (M) sonication, and the number indicates the survival time (in months). The sonication schedules were designed for the delivery of neurotrophic factors, such as GDNF and NTN. It has been reported that the bio-effects induced by GDNF and NTN can last as long as 2 wk (Hoane et al. 1999) . Therefore, we selected biweekly or monthly (a more conservative approach) sonication schemes and carried out behavioral assessments after each sonication up to 24 wk (.30% of their life span). The different survival periods were selected to gain an understanding of when potential damage might have occurred. For each group listed in Table 1 , an age-matched control group (n 5 5) was studied to compare potential behavioral changes. In addition, a sham (S) group (n 5 4, mice were not sonicated, but underwent the procedures) and a positive control (P) group (n 5 8) were also included in this study. For each treatment group, an age-matched control group (no treatment) was studied. Mice were housed under a 12-h-light, 12-h-dark cycle with access to food and water ad libitum. All animal procedures were in accordance with and approved by the Institutional Animal Care and Use Committee of Columbia University.
Experimental setup
A spherical single-element FUS 1.5-MHz transducer was driven by a function generator (Agilent Technologies) through a power amplifier (E&I, Rochester, NY, USA). A 7.5-MHz pulse-echo transducer was positioned through a center hole of the FUS transducer, aligning the foci of the transducers. The pulser-receiver system, which drives the transducer, was connected to a digitizer and used to locate the target of interest (Fig. 1) .
Before the procedure, mice were placed in a chamber filled with 1.25% isoflurane and 0.8 ppm oxygen. Once under anesthesia, the mice were placed prone on a stereotaxic apparatus with continuous flow of the anesthetic mixture. The fur on the scalp was removed using an electric clipper, and remaining hair was completely removed with a depilatory cream. After application of ultrasound gel to the scalp, a degassed water bath with an acoustically and optically transparent polyurethane membrane base was placed on the transducer in contact with the gel above the cranium of the mouse. A grid positioning method was used to identify the striatum of the mouse; this method was similarly used and described in targeting the hippocampus (Choi et al. 2007 ). Briefly, a metallic grid was placed in alignment with the skull sutures of the mouse, which were visible through the intact scalp after hair removal. The striatum was localized by first identifying the lambda suture and then moving the transducer 2.0 mm lateral of the suture and subsequently 6.0 mm anterior from the top of the skull. The focus of the ultrasound beam was located 3.0 mm below the skull.
Sonication protocol
The commercially available ultrasound contrast agent Definity Ò (Lantheus Medical Imaging, North Billerica, MA, USA) microbubbles, which are composed of octafluoropropane gas encapsulated in a lipid shell, were used in this study. The mean diameter of the microbubbles ranges from 1.1 to 3.3 mm. Because of a shortage of the Definity supply, for 3 consecutive wk, in-house manufactured microbubbles were used instead. Similar to Definity, the in-house manufactured microbubbles were also lipid-shelled polydisperse microspheres (mean diameter: 1.4 mm) and had been reported to have similar effects on ultrasound-induced BBB opening (Wang et al. 2014) . The distribution and concentration of both types of microbubbles were measured with a Coulter Counter Multisizer (Beckman Coulter, Fullerton, CA, USA); microbubbles were diluted in phosphate-buffered saline to a final concentration of 8 3 10 8 bubbles/mL before use. A dosage of 1 mL/g body mass was administered via the tail vail immediately before the sonication.
Pulsed FUS parameters include an estimated in situ peak-rarefactional pressure (PRP) of 0.45 MPa (assuming 30% attenuation through the skull according our calibration) with a duration of 60 s, a pulse repetition frequency of 10 Hz and a pulse length of 500 cycles. The control group received no treatment and was housed in the same environment as the treated group. For the positive control group, most parameters were identical to those for the treated group; however, the estimated PRP was increased to 1.5 MPa and pulse length was increased to 10,000 cycles. During each session (biweekly or monthly groups), each subject received a single sonication at the region of interest, while the contralateral side received no treatment. In one cohort, the subjects underwent a sham treatment, in which all procedures were performed (including anesthesia and injection of microbubbles) except for the sonication. Further details of the experimental timeline can be found in Figure 1 .
Magnetic resonance imaging
After each sonication, confirmation of BBB opening was performed using a 9.4-T MRI system (DPX400, Bruker Medical, Boston, MA, USA). The mice were inserted into the vertical MRI bore, and approximately 30 min post-sonication, 2-D FLASH T1-weighted horizontal images of the mouse brain were acquired (TR/TE 5 230/3.3 ms, number of excitations 8, spatial resolution 100 3 100 mm, slice thickness 400 mm) after intraperitoneal injection of an MRI contrast agent. The agent was a gadolinium-based, BBB-impermeable compound (Omniscan, 0.30 mL, molecular weight 573.7 Da). MRI scans used in this study were acquired 80 min post-sonication and 50 min post-gadolinium injection. The volume of BBB opening was quantitatively determined with volumetric measurements of postcontrast T1-weighted MR images . The BBB-opened region was segmented (intensity higher than 2.5 standard deviations of the background) with a manually positioned elliptic cylinder (major diameter 4.3 mm, minor diameter 3.4 mm, height 4.5 mm) over the left striatum following the shape of the focal spot in that plane. An additional elliptic cylinder of the same size was placed on the unsonicated (right) side of the brain. Voxels above the segmentation threshold on the unsonicated side were subtracted from the sonicated side to exclude the vessels and ventricles.
Behavioral testing
Two types of behavioral tests were carried out in this study: open-field test and rotarod performance test. The open-field chamber consisted of a custom-made polycarbonate chamber (dimensions: 27.3 3 27.3 3 27.3 cm) located in an isolated, soundproof room. Directly above the chamber was a video camera, which interfaced with a computer and tracking software (Noldus, Wageningen, Netherlands). All mice underwent 1 week of behavioral training before the first testing session to establish a baseline. Monthly cohorts were tested 2 weeks before the first sonication, and biweekly cohorts were tested 1 week before the first sonication. In addition, mice that received monthly sonications were tested 24 h and 2 weeks after each sonication. The cohorts receiving biweekly treatments were tested 24 h and 1 wk after each sonication.
During open-field testing, the subject was placed directly in the center of the field, and video tracking was used to record and measure activity. Mice explored the field ad libitum for a session duration of 10 min. Movement patterns, such as rearing and the frequency of the mouse standing on the rear legs, were recorded. On completion, the subject was removed, urine and feces were quantified and removed and the chamber was cleaned with ethyl alcohol and disinfectants to remove any trace of the former subject.
Before being placed on the rotarod apparatus (Med Associates, St. Albans, VT, USA), mice were allowed to rest for approximately 10 min. The rod was 32 mm in diameter and gradually accelerated to a maximum of 40 revolutions/min. Each subject was tested for three consecutive trials separated by rest periods of approximately 20 min. Because of the length of the study and the possibility of habituation to falling, during initial training, an acoustic aversive stimulus was used to promote active avoidance of falling. Falling off the rotarod, as well as latching onto the rotarod (rotating with the rod), for two consecutive revolutions was considered the end of a trial.
To assess any abnormalities independent of functional motor activity, anxiety was also measured. Thigmotactic activity in the open field, defined as the tendency to stay on the perimeter of the chamber, was examined to assess axiogenic behavior (Simon et al. 1994) . Time spent within a 6-cm square radiating from the center point of the field was measured in relation to thigmotaxis. In addition, their weight was measured consistently each week to ensure the mice were gaining weight and maintaining adequate nutrition. All comparisons were made against the corresponding age-matched control group, and normalization was done against the established pre-treatment baseline.
Safety assessment
For histologic assessment, mice were sacrificed 1 day after the final behavioral assessment and 1 mo after the last sonication. Mice were sacrificed by transcardial perfusion with phosphate-buffered saline followed by 4% formaldehyde solution. One week after perfusion, post-fixation for paraffin embedding was performed, and brain samples were sectioned at 6 mm with 80 mm trimmed between levels, totaling 10 levels. For each level, the first slide of the brain sample was stained with hematoxylin and eosin (H&E). Two mice from each group were stained with Luxol Fast Blue (H&E-LFB) to stain myelin. Nissl staining was also used to stain for neurons and their nuclei. Morphology was assessed using a bright-field microscope (IX-81, Olympus, Melville, NY, USA) with 43, 103 and 203 objectives.
Statistics
All statistical analysis was performed using SPSS (IBM, Armonk, NY, USA). Weekly weights were analyzed using repeated-measures analysis of variance with a factor of age in weeks. Open-field data gait analysis was performed with repeated analysis of variance with a spatial covariance structure with factors of 5-min intervals (2 per 10-min session) and weeks of age. Motor coordination data were first averaged for the three trials and then subjected to a repeated-measures model with a covariance structure on the repeated measures of age (in weeks) and experimental schedule (in weeks). Normalization was performed by dividing post-treatment and pre-treatment and subtracting by one, then converting the value to a percentage. The significance of the difference between Definity and in-house manufactured microbubbles was determined using a paired t-test. Significance was established at p , 0.05, with high significance at p , 0.01.
RESULTS
Spectra of the signal received by the passive cavitation detector revealed a difference in cavitation dose for 0.45 and 1.5 MPa, with strong broadband noise at 1.5 MPa indicating inertial cavitation (Fig. 2) . The opening of the BBB was confirmed with T1 contrast-enhanced MRI scanning. Figure 3 illustrates the biweekly BBB openings in the same mouse over 5 mo. With the ultrasound parameters used here, it was found that the BBB remained open for a maximum of 2 d, with complete closing on day 3 (see Supplementary Fig. 1 , online only, available at http://dx.doi.org/10.1016/j.ultrasmedbio.2016.05.004). The MRI contrast agent gadolinium diffused efficiently throughout the targeted region of interest, and the opening was reproducible in each mouse after sonication throughout the week. The average opening volume (V BBB ) was determined to be 26.4 6 0.3 mm 3 . No difference in overall behavior was observed because of the transient change from Definity to in-house manufactured polydispersed microbubbles between weeks 8 and 12 for the biweekly groups (p 5 0.287). Because testing began at different times within the year for different groups, it was increasingly important for each group not tested on concurrent days to have a respective age-matched control group. The distance traveled in the open field for the biweekly and sham groups compared with their control remained consistent throughout the testing duration (Fig. 4a) . The positive control exhibited a significant decrease in distance traveled (p , 0.05) when normalized and compared with that for the control (Fig. 4b) . For the monthly groups and their respective controls, no difference was found in distance traveled (p 5 0.429) when tested against time (Fig. 4c ). An increase in overall movement was observed from testing week 0 to the week of sacrifice.
Total mobility time (time during which the subject was moving) was insignificant for all biweekly groups except the positive control (p 5 0.271, positive control: p , 0.01) (Fig. 5a ). There was no decrease in mobility over time as assessed with the two-way repeated-measures analysis of variance against time. However, for the positive control, there was a significant decrease in movement after the first sonication (Fig. 5b) , and there was no statistical significance found in subsequent weeks.
The rotation differential, determined by the net difference between right and left turns (with the threshold for one turn determined by an angle of 120 ), was found to be significant for the positive control, compared with their control group (p , 0.05), for the week after treatment (Fig. 5d) . However, the following weeks were not significant (p 5 0.151) when tested against all biweekly groups.
Except for the positive control, all mice achieved proficiency in their ability to maintain balance and coordination on the rotarod task before exposure to FUS (Fig. 5b) . After treatment, both monthly and biweekly mice were able to complete the task and remain on the rotarod for the expected duration of 180 s over the specified trials (p 5 0.477). For the positive control, there was a significant decrease in the latency to fall off the rod (p , 0.05). Latency did, however, increase in the weeks after initial FUS treatment. Fig. 3 . (a) Two-dimensional horizontal T1-weighted MR images of 5-mo biweekly sonications. Magnetic resonance images were acquired after each sonication and revealed that the blood-brain barrier was successfully and consistently opened at the target area, the striatum, as well as the peak negative pressure of 0.45 MPa. The average volume of opening was 26.49 mm 3 . Permeability of monthly sonication cohort had a survival period of 6 mo. Average volume of opening was consistent with other test groups, and permeability was static throughout the duration of the study. (b) Magnetic resonance image of the sham group to which no sonication was applied reveals no opening at targeted area.
Rearing, defined as the animal standing erect on hind legs, was recorded over the duration of the open-field task and was quantified and measured over time. There was no overall difference in rearing pattern or frequency, with most mice performing the task along the perimeter of the chamber. The positive control, however, did not perform the rearing pattern after the first sonication. Thigmotaxis, defined as the affinity of mice to remain near the perimeter of the open field, was examined for the second half of the open-field test. All treated groups and their controls exhibited similar travel patterns and explored the center of the open field (Fig. 6a, d ). The positive control before sonication exhibited normal travel patterns associated with low anxiety; however, after sonication, the overall decrease in mobility reflected abnormal travel patterns (Fig. 6e, f) . The sham mice displayed anxiogenic behavior (Fig. 6g, h) , with decreases in weight, rearing and overall mobility during weeks 4 and 5 (Fig. 7) . When each subject within the group was examined individually, only one did not display the decreased mobility and had an increase in weight. On the basis of this observation, the non-anxiogenic subject, perceived to be the aggressor, was separated, and the remaining mice eventually were able to gain and maintain normal weight distribution based on age, as well as decreased anxiogenic behavior (Figs. 6g, h and 7) .
Histological analysis was used to detect any permanent damage to the brain, specifically within the region receiving treatment (Fig. 8a-f) . For all treated cohorts including the positive control with a survival of 4 wk after treatment, there was no evident damage; myelination appeared normal, and no cohort exhibited significant evidence of dark or ischemic neurons. The positive control at 1.5 MPa maintained a morphology similar to that of the 0.4-MPa-treated groups (Fig. 8a-c) . However, the positive control with a survival of 24 h had extravasated erythrocytes (Fig. 8d-f) . When staining for Nissl, loss of neuronal bodies was observed in the positive control at the location of FUS treatment (Fig 9a-c) , whereas there was no loss of neuronal bodies in the untreated contralateral hemisphere (Fig. 9d-f) .
DISCUSSION
The longitudinal analysis of FUS presented herein yields a set of parameters with which FUS may be applied , and all groups were tested on the same day. P1 and B3 were tested on different days and, therefore, had separate controls. *Represents the difference between group P and their control. (b) Distance traveled was normalized from baseline trial to post-treatment treatment and subtracted by one. Normalization of distance traveled after week 1 (24 h after sonication) shows a significant decrease in distance traveled for the positive control, whereas the other groups maintained a stable pattern post-sonication. (c) Variances in distance traveled for monthly cohorts. There was no significant time-related effect for the monthly treated groups. Patterns of travel remained consistent with their controls throughout the (maximum) 6-mo duration. SEM plotted. *p , 0.05.
without causing structural or behavioral deficiencies. Though FUS has many applications, this is the first study to investigate behavioral and motor deficits with durations of up to 6 months in mice. Sonication was performed either on a biweekly or monthly basis. As previously discussed, MRI is shown to be reliable in monitoring and confirming BBB opening and volume. By using open-field and rotarod testing paradigms, as well as histologic processing, we were able to quantify and analyze behavior, as well as to examine abnormalities, that may be attributed to FUS. Openfield testing was used as a measure of both ambulatory activity and anxiogenic activity, whereas the rotarod was used to monitor motor coordination and, where damage was evident, examine the extent of motor instability (Luzzati et al. 2007 ). Both open-field and rotarod tests are of special relevance in this study because of the required use of the striatum, as it is involved in fine motor control. In our study, injury to the striatum, as suggested by MRI and visualized in histology, is consistently manifested behaviorally. Both paradigms have been established and are able to detect cerebral abnormalities (Fujimoto et al. 2004) . Overall, all groups tested (apart from the positive control) exhibited no abnormal behavior.
Despite the fact that some individual mice experienced an overall decrease in movement, individual characteristics must be examined with a comprehensive approach, whereby certain attributes are considered more indicative evidence than others. Though a vast decrease in distance traveled may initially be attributed to severe cerebral damage (Klein et al. 2012 ), a lack of evident deficits in any other ambulatory behavior, most emphatically rotation differential, suggests that the decrease may be due to a factor unrelated to FUS treatment, such as environmental factors (Brooks and Dunnett 2009) . For all groups, there was no observed effect related to age, with the oldest subject being sacrificed at approximately 8 mo of age. The only group with significant difference in each variable examined was the positive control. Decrease in motor function and coordination was apparent at a peak negative pressure of 1.5 MPa. However, the cohort was able to recover from the injury, and histologic analysis of the cerebral morphology 4 wk after application of ultrasound revealed a decrease in neurons and no other gross abnormalities. Except for the positive control, the mice remained static throughout the study. (c) However, monthly groups experienced an overall increase in movement over time. (b) Normalized rotarod from initial trial to first treatment. After learning, the mice were able to complete the task, and there was no significant difference between group performances, except for the positive control. The P1 control is plotted; however, the group achieved proficiency on the task in week 0. (d) Rotation differential was determined as the net difference in the turn direction. Negative deviation of the rotation differential strongly suggests damage from sonication. Unilateral cerebral damage would cause hemiparesis or hemiparalysis. The positive control displayed a significant affinity to the side corresponding to the sonication, supporting the damage finding.
No other groups exhibited a similar pattern. SEM plotted. *p , 0.05. Confirmation of paradigm sensitivity was manifested by the positive control, which exhibited the phenotypic characteristics of severe motor damage. These characteristics include overall decreased locomotor activity and rotation affinity toward the side ipsilateral to damage because of paralysis of the contralateral hemisphere of the subject.
The accelerating rotarod is a paradigm heartily accepted for motor sensitivity and testing (Hamm et al. 1994) and revealed no significant difference in latency to fall between groups, further supporting the notion of no damage. The positive control was unable to complete the accelerating rotarod task after the first sonication but, at the time of sacrifice, was able to maintain coordination and balance for the measured duration (Fig. 5) .
Differences in anxiogenic behavior throughout the week between treated and control mice for almost all cohorts were not statistically significant. Though rearing reflects motor coordination, it is also indicative of anxiety. There were no significant differences between treated cohorts in rearing frequency and pattern, as well as thigmotaxis (except for the positive control that exhibited poor movement). The sham, S5, exhibited increased anxiety as a result of exposure to a perceived threatening stimulus. In four mice, there was increased expression of thigmotaxis and a decrease in weight below the average for the age range (Kozak et al. 2010) , which were elicited by one aggressive mouse; the aggressor exhibited no abnormal anxiogenic behavior and maintained an average weight (Fig. 7) . Once provided separate cages, the sham group experienced decreased anxiogenic behavior and achieved normal weight gain (Fig. 7) . The results indicate that FUS has no effect on anxiety behavior in the normal mice. Traumatic brain injury has also been reported to increase anxiogenic behavior in mice (Brooks and Dunnett 2009) .
The rotation differential is a widely used method for detecting unilateral damage, and remained a strong indicator in the presented study. Negative deviation constituted damage, and typically, all other motor behaviors followed the inclination of the rotation differential. Negative differential was also observed to be parallel with significantly lower ambulatory movement, as well as poor performance on the rotarod.
The use of in-house manufactured bubbles was found not to cause behavioral alterations and provided an additional paradigm with which to examine the importance of microbubble composition. Carbon chains forming the lipid shell of the in-house made microbubble encapsulated the perflurobutane gas. Definity microbubbles are made of a proprietary perflutren lipid-coated shell that encapsulates octafluropropane gas. Definity has received approval from the U.S. Food and Drug Administration for use as a contrast agent in cardiac imaging. When examining differences from weeks 8 to 12 of the 5-month biweekly group (which received the most frequent sonications), it was found that despite variances in composition, both types of bubbles can induce tolerable BBB opening and do not alter behavior at the parameters tested.
Previous studies from our group reported that the parameters cited in this study are not the only parameters that may be applied without causing damage . Methods of examining alternate variables in the previous studies were based on histologic processing (Baseri et al. 2010) . However, the results from our previous studies provided a reference for the upper limit of the pressure variable without inducing damage . Most pressures at and below 0.45 MPa, but above 0.30 MPa, using Definity microbubbles have been found to open the BBB without causing cerebral damage (Choi et al. 2010a ). However, cerebral damage can occur if ultrasound parameters are not carefully chosen. In this study, we deliberately chose 1.5 MPa for the positive control group to illustrate behavior changes in these mice. A significant decrease in motor function and coordination is apparent at a peak and after sonication (e, f) is also illustrated and reveals a significant decrease between weeks. (g) A sham mouse exhibited increased anxiety caused by an aggressive mouse in the same cage. The wounded mouse displayed an increase in anxiety.
Two weeks after the aggressor was removed, the same mouse exhibited normal behavior (h).
= Fig. 7 . Weight gain of mice throughout week of testing.
Comparison of 100 C57BL/6 mice on a 6% fat diet. According to the data provided by Jackson Laboratories, the weight distribution over age was normal up to 20 wk. The sham group experienced a decrease in weight because of an aggressive mouse (unrelated to focused ultrasound). On separation, the mice recovered and eventually regained to a healthy weight. *Represents the difference between sham and Jackson Laboratories data. SD plotted. *p , 0.05.
negative pressure of 1.5 MPa (Fig. 4a, c) . Nonetheless, all mice were able to recover from the injury; in addition, it was found through histologic analysis that the cerebral morphology 4 wk after application of ultrasound was close to that of group B1 (Fig. 8) , with a survival period of 4 wk and a peak negative pressure within the safety (0.45 MPa) window, suggesting damage was reversible . Histological analysis revealed no differences in damage between groups over durations ranging from 1 to 6 months of survival with repeated FUS application, including the n 5 5 group P that was sacrificed 1 month after sonication (Fig. 9 ). The group P mice (n 5 3), which were sacrificed 24 h after sonication, had extravasated erythrocytes as well as dark neurons (Fig. 8) .
Other researchers have reported the tolerability and feasibility of BBB opening with FUS in other animals. The procedure has been assessed in rats (Kim et al. 2014 ) and rabbits McDannold et al. 2005) , and tolerability has been further assessed behaviorally in non-human primates (Downs et al. 2014; McDannold et al. 2012) .
Clinical implications
The study described here illustrates the potential and feasibility of using FUS as a form of treatment and essentially eliminates the issues of drug size, hydrophobicity and other limiting factors for delivery. The use of FUS for delivery of drugs is not limited to Parkinson's disease; it can be used in many neurodegenerative diseases, such as Alzheimer's. For Parkinson's, however, FUS offers the possibility of decreasing and potentially eliminating the dependence on carbidopa for delivery of levodopa.
Further examination of the potential of alternative therapies will result in a variety of therapeutic agents. Neurotrophic factors are endogenous to the brain and other organs, and with FUS, a protein brain-derived neurotrophic factor with a molecular weight of 27 kDa is able to cross the BBB and retain biological activity (Baseri et al. 2012) . Other neurotrophic factors that have been found to permeate the BBB using FUS include neurturin (23.6 kDa) and adenoassociated viruses (4 MDa) expressing glial-derived neurotrophic factor , both of which are potential candidates for Parkinson's disease therapy. Fig. 8 . Histologic analysis using hematoxylin and eosin followed by Luxol Fast Blue staining of paraffin-embedded sections revealed no red blood cell extravasation or dark neurons for all groups, including the positive control at week 4 (a-c). There was also no other abnormal morphology. However, sacrifice at 24 h after sonication revealed hemorrhage (arrow) in the positive control, group P* (d-f). Brains were sectioned horizontally at 6 mm. Bar 5 (a) 1 mm, (b) 200 mm and (c) 50 mm. One area of future study is neuronal plasticity as it relates to FUS. Though the positive control manifested extensive damage 24 h after sonication, 1 month after the high-pressure treatment, no damage was evident, suggesting BBB restoration.
Elucidation of the mechanism underlying repair of the striatum is worthwhile to re-examine whether neurogenesis occurs in the striatum, which was previously suggested to be a site of low neurogenesis (Luzzati et al. 2007) .
CONCLUSIONS
This tolerability and feasibility study of repeated BBB opening using FUS in conjunction with microbubbles used FUS over an extended period and examined behavioral changes associated with the treatment. We assessed the chronic (.6 months) use of FUS at the same location found that it does not cause any motor, behavioral or morphologic deficits or alterations. These results support the use of FUS as a safe alternative or complementary non-invasive drug delivery method. 
